Simulations Plus to Participate in the BTIG Digital Health Forum

Rhea-AI Summary

Simulations Plus (Nasdaq: SLP), a leading biosimulation and medical communications solutions provider, announces its participation in the upcoming BTIG Digital Health Forum on November 25, 2024. CEO Shawn O'Connor will join a panel discussion on 'Supporting Drug Development, Clinical Trials, and Biopharma' at 2:00 p.m. Eastern Time and conduct one-on-one meetings throughout the day. Interested participants must pre-register through the BTIG website to attend the virtual event.

LANCASTER, Calif.--(BUSINESS WIRE)-- Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of biosimulation, simulation-enabled performance and intelligence solutions, and medical communications for the biopharma industry, today announced that Shawn O’Connor, chief executive officer, will participate in the virtual BTIG Digital Health Forum on Monday, November 25, 2024. Mr. O’Connor will join a panel discussion entitled “Supporting Drug Development, Clinical Trials, and Biopharma” at 2:00 p.m. Eastern Time. In addition, Mr. O’Connor will host one-on-one meetings throughout the day.

For more information about the BTIG Digital Health Forum, or to register to attend, please visit the BTIG website. For more information about the event, email uscorporateaccess@btig.com. Please note that participants must be pre-registered to attend.

About Simulations Plus

With more than 25 years of experience serving clients globally, Simulations Plus stands as a premier provider in the biopharma sector, offering advanced software and consulting services that enhance drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. Our comprehensive biosimulation solutions integrate artificial intelligence/machine learning (AI/ML), physiologically based pharmacokinetics, quantitative systems pharmacology/toxicology, and population PK/PD modeling approaches. We also deliver simulation-enabled performance and intelligence solutions alongside medical communications support for clinical and commercial drug development. Our cutting-edge technology is licensed and utilized by leading pharmaceutical, biotechnology, and regulatory agencies worldwide. For more information, visit our website at www.simulations-plus.com. Follow us on LinkedIn | X | YouTube.

Environmental, Social, and Governance (ESG)

We focus our Environmental, Social, and Governance (ESG) efforts where we can have the most positive impact. To learn more about our latest initiatives and priorities, please visit our website to read our 2023 ESG update.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241119690966/en/

Simulations Plus Investor Relations

Cristin Ryman

984-444-8358

cristin.ryman@simulations-plus.com

Financial Profiles

Lisa Fortuna

310-622-8251

slp@finprofiles.com

Source: Simulations Plus, Inc.

FAQ

When is Simulations Plus (SLP) participating in the BTIG Digital Health Forum?

Simulations Plus (SLP) is participating in the BTIG Digital Health Forum on Monday, November 25, 2024.

What panel discussion will Simulations Plus (SLP) CEO participate in at the BTIG Forum?

CEO Shawn O'Connor will participate in the panel discussion 'Supporting Drug Development, Clinical Trials, and Biopharma' at 2:00 p.m. Eastern Time.

How can investors attend the BTIG Digital Health Forum featuring Simulations Plus (SLP)?

Investors must pre-register through the BTIG website to attend the virtual event. They can also email uscorporateaccess@btig.com for more information.

What activities will Simulations Plus (SLP) CEO conduct at the BTIG Forum?

CEO Shawn O'Connor will participate in a panel discussion at 2:00 p.m. Eastern Time and host one-on-one meetings throughout the day.